400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / c-Met/HGFR / PF-04217903
CAS No.: 956905-27-4
Synonyms: PF-4217903
PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM, susceptible to oncogenic mutations (no activity to Y1230C mutant).
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00706355 | Neoplasms | Phase 1 | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | United States, Colorado ... more >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48201 Collapse << |
NCT00706355 | - | - | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | - |
实验方案
技术信息
CAS号 | 956905-27-4 | 储存条件 |
|
|||||||||||
分子式 | C19H16N8O | 运输 | 蓝冰 | |||||||||||
分子量 | 372.38 | 别名 | PF-4217903 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
human A549 cells | - | Function assay | 1 h | Antagonist activity at c-MET receptor in human A549 cells assessed as inhibition of autophosphorylation after 1 hr by ELISA, IC50=4 nM | 22924734 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00706355 | Neoplasms | Phase 1 | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | United States, Colorado ... more >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48201 Collapse << |
NCT00706355 | - | - | Terminated(See termination rea... more >>son in detailed description.) Collapse << | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网